Apyx Ebitda from 2010 to 2024

APYX Stock  USD 1.61  0.08  4.73%   
Apyx Medical EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Apyx Medical EBITDA regression line of annual values had slope of (1,705,029) and arithmetic mean of (9,353,813). View All Fundamentals
 
EBITDA  
First Reported
2000-03-31
Previous Quarter
-5 M
Current Value
-3.6 M
Quarterly Volatility
2.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 736.2 K, Interest Expense of 2.6 M or Selling General Administrative of 51.3 M, as well as many indicators such as Price To Sales Ratio of 1.65, Dividend Yield of 0.0 or PTB Ratio of 3.23. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.
  
Check out the analysis of Apyx Medical Correlation against competitors.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Ebitda Growth Pattern

Below is the plot of the Ebitda of Apyx Medical over the last few years. It is Apyx Medical's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Apyx Ebitda Regression Statistics

Arithmetic Mean(9,353,813)
Coefficient Of Variation(90.08)
Mean Deviation7,625,961
Median(6,174,000)
Standard Deviation8,425,707
Sample Variance71T
Range23.9M
R-Value(0.90)
Mean Square Error13.8T
R-Squared0.82
Slope(1,705,029)
Total Sum of Squares993.9T

Apyx Ebitda History

2024-17.2 M
2023-18.1 M
2022-22 M
2021-13.9 M
2020-18.5 M
2019-19.9 M
2018-13.1 M

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-18.1 M-17.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.